Virtual 5th Annual Chronic Traumatic Encephalopathy Conference

October 21, 2021 to October 22, 2021

 

Chronic Traumatic Encephalopathy (CTE) is a progressive degenerative disease of the brain found in athletes (and others) with a history of repetitive brain trauma, including symptomatic concussions as well as asymptomatic subconcussive hits to the head. Brain degeneration is associated with memory loss, confusion, impaired judgment, impulse control problems, aggression, depression, and, eventually, progressive dementia.

​During this virtual two-day course participants will learn about all aspects of CTE including its pathology, pathophysiology, genetics, biomarkers, imaging, clinical syndromes, clinical criteria, differential diagnosis, impact on veterans and implications for the family, and what it is like to live with or worry about the disease.

​This Conference is for Intermediate and Advanced clinicians.

Poster Session - Call for Abstracts

The BU Alzheimer’s Disease Research Center is now accepting abstracts for the 2021 CTE Conference poster session. The call for posters is open to students of all levels, trainees, researchers, and faculty who are involved in research related to Alzheimer’s disease, dementia, aging, and related topics. Poster abstracts are due Tuesday, September 7, and must be submitted online. Accepted poster presenters will be notified by Tuesday, September 14. 

Target Audience

  • Coaches
  • Dementia Specialists
  • Graduate & Postdoctoral Students
  • Neurologists
  • Neuropathologists
  • Neuropsychologist
  • Neurosurgeons
  • Nurses & Nurse Practitioners
  • Physical Therapists
  • Physicians & Physicians Assistants
  • Psychiatrists
  • Psychologists
  • PTSD Specialists
  • Radiologists
  • Rehabilitative Services
  • Researchers
  • Sport Psychology Consultants

Learning Objectives

Through lectures, question and answer sessions, and panel discussions participants at the conclusion of this conference will be able to:

  •     Identify the pathology of CTE
  •     Describe the clinical syndrome of CTE
  •     Identify bio markers of CTE
  •     Describe the co-morbidity of Alzheimer’s Disease & related disorders
  •     Identify the risk factors of CTE
  •     Identify different types of exposures for CTE
Course summary
Available credit: 
  • 15.25 AMA PRA Category 1 Credit™
    Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Boston University School of Medicine designates this Live activity for a maximum of 15.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 15.25 Participation
Course opens: 
07/19/2021
Course expires: 
10/21/2022
Event starts: 
10/21/2021 - 10:00am
Event ends: 
10/22/2021 - 6:00pm
Cost:
$325.00
Rating: 
0

All times EST

Thursday, October 21, 2021 
  
10:00 AM - 10:05 AMWelcome (Kate Turk, MD & Andrew Budson, MD)
  
10:05 AM - 10:50 AMCTE—Historical Perspectives [concussion, post-concussion, CTE disentangled] (Robert Cantu, MD)
  
10:50 AM -11:50 AMNeuropathology of CTE (Ann McKee, MD)
  
11:50 AM -12:00 PMCoffee Break / Poster session
  
12:00 PM - 12:50 PMClinical Outcomes and Features of Repetitive Head Trauma (Robert Stern, Ph.D.)
  
12:50 PM - 1:40 PMLunch Break / Poster session
  
1:40 PM - 2:00 PMQ & A (Morning Faculty)
  
2:00 PM - 2:50 PMGenetics, Risk, Exposure, Family History (Jesse Mez, MD)
  
2:50 PM - 3:40 PMCriteria for Traumatic Encephalopathy Syndrome (Doug Katz, MD)
  
3:40 PM - 4:30 PMMechanisms of CTE (Lee Goldstein, MD, Ph.D.)
  
4:30 PM - 4:40 PMCoffee Break / Poster Session
  
4:40 PM - 5:00 PMQ & A (Afternoon Faculty)
  
5:00 PM - 6:00 PMFamily Panel 
  
Friday, October 22, 2021 
  
9:00 AM -10:00 AMPoster Session
  
10:00 AM - 10:05 AMWelcome (Kate Turk, MD & Andrew Budson, MD)
  
10:05 AM -10:35 AMMRI Imaging in Traumatic Brain Injury (Jasmeet Hayes, PhD)
  
10:35 AM -11:05 AMPET Imaging as a Biomarker for CTE (Guest Speaker)
  
11:05 AM -11:50 AMFluid biomarkers in CTE (Kaj Blennow, MD) 
  
11:50 AM -12:00 PMCoffee Break / Poster session
  
12:00 PM - 12:40 PMDifferential Diagnosis and Treatment of Mild TBI and CTE (Kate Turk, MD)
  
12:40 PM -1:00 PMQ & A (Morning Faculty)
  
1:00 PM - 2:00 PMLunch / Poster Session
  
2:00 PM - 2:50 PMContact Sports and Risk of Neurodegenerative Disease Beyond CTE (Thor Stein, MD, Ph.D.)
  
2:50 PM - 3:40 PMVascular Contributions to Cognitive Impairment and dementia in former athletes (Michael Alosco, Ph.D.)
  
3:40 PM - 3:50 PMCoffee Break / Poster session
  
3:50 PM - 4:30 PMBlack former football players/family members raising the issue of stress and other issues related to racism and discrimination—stressing these issues when considering diagnoses. (Guest Speaker)
  
4:30 PM - 5:00 PMAfternoon + Whole course Q & A (All Faculty)
  
5:00 PM - 6:00 PMPerception of Athlete Concerns – (Chris Nowinski, PhD)

Boston University School of Medicine asks all individuals involved in the development and presentation of Accredited Continuing Education activities to disclose all financial relationships with ineligible companies. This information is disclosed to all activity participants prior to the start of the educational activity. Boston University School of Medicine has procedures to mitigate all relevant financial relationships with ineligible companies. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed. 

Michael Alosco, Ph.D.
Assistant Professor of Neurology, Boston University School of Medicine

Kaj Blennow, MD
Professor/ Chief Physician
Department of Psychiatry and Neurochemistry, University of Gothenburg

Andrew Budson, MD (Course Co-Director)
Chief of Cognitive & Behavioral Neurology, Associate Chief of Staff for Education, and Director of the Center for Translational Cognitive Neuroscience at the Veterans Affairs (VA) Boston Healthcare System, Associate Director for Research at the Boston University Alzheimer’s Disease Center, Professor of Neurology at Boston University School of Medicine, and Lecturer in Neurology at Harvard Medical School.

Robert Cantu, MD, FACS
Medical Director and Director of Clinical Research at the Cantu Concussion Center at Emerson Hospital, Concord, MA.

Lee Goldstein, MD, Ph.D.
Associate Professor, Biomedical Engineering, Associate Professor, Psychiatry, Neurology, Opthalmology, Pathology and Laboratory Medicine, Director, Molecular Aging and Development Laboratory, Director, Translation Core, NIH Alzheimer’s Disease Center, Director, Center for Biometals & Metallomics (CBM), Director, Molecular Biophotonics Laboratory (MBL)

Jasmeet Hayes, PhD
Associate Professor, Clinical Area, Department of Psychology, Boston University

Douglas Katz, MD
Professor of Neurology, Boston University School of Medicine

Ann Mckee, MD
Professor of Neurology & Pathology
, Director, Neuropathology Core
William Fairfield Warren Distinguished Professor of Neurology and Pathology at Boston University, Director of Neuropathology for VA Boston, and Director of the BU Chronic Traumatic Encephalopathy (CTE) Center. 

Jesse Mez, M.D., M.S.
Associate Professor of Neurology, Boston University School of Medicine
Alzheimer’s Disease Center Clinical Core Associate Director

Chris Nowinski, PhD
Co-Founder, CEO, Concussion Legacy Foundation

Thor Stein, MD, Ph.D.
Associate Professor of Pathology and Laboratory Medicine
Associate Director of the Neuropathology Core of the Boston University Alzheimer Disease Center

Robert Stern, PhD
Professor of Neurology, Neurosurgery, and Anatomy & Neurobiology, Boston University School of Medicine, Director of Clinical Research, CTE Center

Kate Turk, MD (Course Director)
Assistant Professor, Neurology
Boston University School of Medicine

CME Program Manager - Naomi Moeller

Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Boston University School of Medicine designates this live activity for a maximum of 15.25 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. 

Available Credit

  • 15.25 AMA PRA Category 1 Credit™
    Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Boston University School of Medicine designates this Live activity for a maximum of 15.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 15.25 Participation

Price

Cost:
$325.00
Please login or register to take this course.

Registration Fee:

Clinicians - $325

Students/Resident Assistants - Free


BUSM CME complies with the ADA and the rules and regulations thereof to make reasonable accommodations for our educational activities. If any participant in this educational activity is in need of accommodations, please contact BUSM CME at cme@bu.edu.

Cancellation Policy:

Substitutions may be made at any time without an additional charge.  Refunds, less an administrative fee of $75, will be issued for all cancellations received two weeks prior to the start of the conference.  Should cancellation occur within the two-week window, a credit will be issued, not a refund.  Credits will be honored for up to two years.  “No shows” are subject to the full course fee.  Cancellations/substitution(s) must be made in writing.  Refunds or credits will not be issued once the conference has started.  This course is subject to change or cancellation.